Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ETHYL METHYL HYDROXYPYRIDINE MALATE OR PHARMACEUTICAL COMPOSITION THEREOF, AND A USE IN PREVENTING AND/OR TREATING TYPE-II DIABETES
Document Type and Number:
WIPO Patent Application WO/2021/012694
Kind Code:
A1
Abstract:
A use of an ethyl methyl hydroxypyridine malate or a pharmaceutical composition containing said compound and a pharmaceutically acceptable excipient in preparing a drug, said drug being used to prevent and/or treat a disease caused by a disorder related to insulin resistance or a disease caused by pancreatic beta cell damage, used to treat and/or prevent type-II diabetes, used to protect pancreatic beta cells and reduce insulin resistance, and used to promote the secretion function of pancreatic beta cells, regulate oxidative stress, and reduce the risk of occurrence of and illness from type-II diabetes.

Inventors:
KISELEVA ANASTASIIA (CN)
SAMARINA NATALIA (CN)
KALINCHENKO SVETLANA (RU)
VORSLOV LEONID (RU)
Application Number:
PCT/CN2020/080782
Publication Date:
January 28, 2021
Filing Date:
March 24, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KENO PHARMA LTD (CN)
International Classes:
A61K31/44; A61P3/10; A61P5/50
Foreign References:
RU2158590C12000-11-10
RU2377237C12009-12-27
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF: